Compare Church & Dwight Co., Inc. (CHD) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Church & Dwight Co., Inc. vs ResMed Inc. — how do they compare? Church & Dwight Co., Inc. trades at $103.35 (market cap $24.38B), while ResMed Inc. trades at $220.4 (market cap $32.61B). The key difference: ResMed Inc. is the larger of the two by market cap, and Church & Dwight Co., Inc. pays the higher dividend (1.2%). Which is the better fit depends on your goals.
| CHD | RMD | |
|---|---|---|
Market Cap | $24.38B | $32.61B |
Sector | Consumer Staples | Health |
52-Week High | $105.26 | $293.73 |
52-Week Low | $81.60 | $182.82 |
Enterprise Value | $26.38B | $31.97B |
Dividend Yield | 1.2% | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Church & Dwight Co., Inc.
Church & Dwight is the leading producer of baking soda in the world. Beyond baking soda, the products in its portfolio have vast category reach, including laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Xtra, Trojan, OxiClean, First Response, Nair, L'il Critters/Vitafusion, Orajel, and WaterPik, which together with Arm & Hammer constitute more than 80% of its annual sales and profits. In early 2019, the firm announced the addition of Flawless, which manufactures electric shaving products for women. At the end of 2020, the firm acquired Zicam, a leading brand in the cough/cold-shortening category. Church & Dwight derives more than 80% of its sales from its home market in the U.S.
Read more on CHD →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
